As fibrosis progresses, "bridges" of extracellular matrix appear between cells. |
Interdisciplinary research at the University of Pennsylvania is showing
how cells interact over long distances within fibrous tissue, like that
associated with many diseases of the liver, lungs and other organs.
By developing mathematical models of how the collagen matrix that
connects cells in tissue stiffens, the researchers are providing
insights into the pathology of fibrosis, cirrhosis of the liver and
certain cancers.
Tissue stiffness has long been know to be clinically relevant in
these diseases, but the underlying changes that alter the mechanics of
tissues are poorly understood. Consisting of a complex network of
fibers, tissues have proven difficult to simulate and model beyond
local, neighbor-to-neighbor interactions.
Developing a better understanding of the large-scale mechanical
changes that occur over longer distances, specifically the process by
which the extracellular matrix is pulled into compact, highly-aligned
"bridges," could eventually form the basis of treatments for related
diseases.
Vivek Shenoy, professor in the Department of Materials Science and
Engineering in Penn's School of Engineering and Applied Science, has led
an interdisciplinary research team to tackle this problem, authoring a
pair of papers that were published in Biophysical Journal.
One, "Remodeling of Fibrous Extracellular Matrices by Contractile
Cells: Predictions from Discrete Fiber Network Simulations" involved
developing simulations that extrapolated the overall remodeling of the
extracellular matrix based on the behavior of neighboring pairs of
cells. The other, "Long Range Force Transmission in Fibrous Matrices
Enabled by Tension-Driven Alignment of Fibers," took a more mathematical
approach, producing a coarse-grained model of this remodeling that
could be more broadly applied to fibrotic tissue.
"We're trying to understand how force is transmitted in tissues,"
Shenoy said. "Cells are the ones that generate force, and it has to be
transmitted through what surrounds the cell, the extracellular matrix,
or ECM. But imagine trying to model the ECM by trying to keep track of
each collagen fibril in your liver; there are tens of millions of those.
So we're taking what we learn from simulating those networks to turn it
into a model that captures the main features with only a few
parameters.
"The key here is the mechanics," he said. "In particular, how does
ECM, as a fibrous material, differ from solids, gels and other materials
that are better studied."
Rebecca Wells, an associate professor in Penn's Perelman School of
Medicine and a co-author on the latter paper, provided insight into the
clinical relevance of the mechanics that characterize ECM-related
disorders.
"Fibrosis occurs when you have an injury and the tissue responds by
depositing ECM, forming scar tissue," Wells said. "In liver fibrosis,
the liver can stiffen by up to an order of magnitude, so measuring
stiffness is a common diagnostic test for the disease. Increased
stiffness also occurs in cancer, where tumors are typically stiffer than
the surrounding tissue."
Existing experimental evidence showed that mechanical forces were at
play in the changes in both fibrosis and cancer and that these forces
were important to their development and progression but could not
explain the long-ranging changes cells were able to produce to change
their environments. When put in tissue-simulating gels, cells can deform
their immediate surroundings but are unable to pull on more distant
cells. In real, ECM-linked tissue, however, cells' range of influence
can be up to 20 times their own diameter.
"If you look at a normal tissue," Shenoy said, "you see the cells are
more rounded, and the network of ECM fibers is more random. But as
cancer progresses, you see more elliptical cells, more ECM, and you see
that the ECM fibers are more aligned. The cells are the ones generating
force, so they're contracting and pulling the fibers, stretching them
out into bridges."
"That's also the pathology of cirrhosis," Wells said. "My group had
been looking at the early mechanical changes associated with liver
fibrosis, which progresses to cirrhosis, but then, by collaborating with
Vivek, we started to wonder if these large scale changes in the
architecture of the liver could have a mechanical basis and if something
similar to what is seen in gels might be occurring in the liver. This
is a new way of approaching the problem, which has largely been thought
of as biochemical in origin. And there are other tissues where it is
probably the same thing, the lung, for example."
The researchers found that the critical difference between the
existing models and ECM's long-range behavior was rooted in its elastic
properties. Materials with linear elasticity cannot transmit force over
the distances observed, but the team's simulations showed that nonlinear
elasticity could arise from the ECM's fibrous structure.
"In our model, every component is linearly elastic," Shenoy said,
"but the collective behavior is nonlinear; it emerges because of the
connectivity. When you deform the network, it's easy to bend the
'sticks' that represent collagen fibers but hard to stretch them. When
you deform it to a small extent, it's all the bending of the fibers,
but, as you deform further, it can't accommodate bending any more and
moves over to stretching, forming the bridges we see in the tissue."
Such simulations can't predict which fibers will end up in which
bridge, necessitating the coarser-grained model the researchers
described in their second paper. By showing the point at which linear
elasticity gives way to its nonlinear counterpart, the team produced a
more complete picture of how the alignment of collagen bridges under
tension transmit force between distant cells.
Further studies are needed to elucidate the feedback loops between
ECM stiffening and cell contraction strength. The team is conducting
physical experiments to confirm and refine their in silico findings.
"Right now," Wells said," we're hypothesizing that the mechanical
interactions modeled by the Shenoy lab explain aspects of cancer and
fibrosis, and we're developing the experimental systems to confirm it
with real cells."
No comments:
Post a Comment